FOUNDERS ›

Varda

Private

Private

Drug crystals grown in orbit

Drug crystals grown in orbit

Drug crystals grown in orbit

Spacecraft that make drug crystals in orbit and fly them home

A Varda reentry capsule on a test fixture
A Varda reentry capsule on a test fixture

FOUNDED

2021

FOUNDERS

Will Bruey and Delian Asparouhov

HEADQUARTERS

El Segundo, California

STATUS

Private

WEBSITE

Visit website

Some drug molecules crystallize differently without gravity. On Earth, sedimentation and convection disturb a growing crystal. In orbit those forces mostly fall away, which can yield more uniform crystals and forms that are hard to make on the ground. Varda’s first capsule, W-1, did this with the HIV drug ritonavir between 2023 and 2024.

The hard part is the trip home. Varda builds the whole vehicle in El Segundo. A satellite bus runs the experiment. Then a capsule separates and hits the atmosphere at about Mach 25, protected by a C‑PICA carbon ablator that NASA developed and Varda now makes in house. A parachute sets it down in South Australia.

On November 5, 2026, W-8 landed after 35 days in orbit. It was Varda’s seventh reentry since 2024. Five weeks earlier, Varda raised $251 million at a $1.6 billion valuation.

Company facts from public sources, November 2026

Blackletter Capital LLC (“Blackletter”) maintains the websites blackletter.com and ligature.vc. Information with respect to Ligature is available through ligature.vc. Blackletter does not solicit, offer, or sell securities via the Internet. Any representations to the contrary and any websites other than blackletter.com and ligature.vc are not endorsed by Blackletter. Our equity strategies are model portfolios, closed to new capital. Nothing on this site is investment advice.

B

Headquarters

885 Arapahoe Ave

Boulder, CO 80302

Receive our quarterly and annual letters

Blackletter and the Blackletter mark are trademarks of Blackletter Capital LLC

© 2026 Blackletter Capital LLC

B

Headquarters

885 Arapahoe Ave

Boulder, CO 80302

Receive our quarterly and annual letters

Blackletter and the Blackletter mark are trademarks of Blackletter Capital LLC

© 2026 Blackletter Capital LLC

Blackletter Capital LLC (“Blackletter”) maintains the websites blackletter.com and ligature.vc. Information with respect to Ligature is available through ligature.vc. Blackletter does not solicit, offer, or sell securities via the Internet. Any representations to the contrary and any websites other than blackletter.com and ligature.vc are not endorsed by Blackletter. Our equity strategies are model portfolios, closed to new capital. Nothing on this site is investment advice.